Company Encyclopedia
View More
name
ZOMEDICA CORP
ZOMDF.US
1.407 T
ZOMDF.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
Health Care EquipmentIndustry
Industry Ranking84/171
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-52.41%E
    • Profit Margin-286.96%E
    • Gross Margin67.15%A
  • Growth ScoreC
    • Revenue YoY10.20%B
    • Net Profit YoY-35.90%D
    • Total Assets YoY-38.86%E
    • Net Assets YoY-41.00%E
  • Cash ScoreC
    • Cash Flow Margin-34.85%D
    • OCF YoY10.20%B
  • Operating ScoreD
    • Turnover0.17D
  • Debt ScoreA
    • Gearing Ratio8.57%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Zomedica’s Sales VP Makes Bold Stock Purchase!

    Klass Russell Kevin, Zomedica's Senior VP of Sales, purchased 150,000 shares, signaling confidence in the company. Zomedica reported a 16% revenue increase in Q3 2025, driven by strong demand and new revenue streams, but faces profitability challenges with a $6.1 million net loss and delisting risks. Analysts have mixed views, citing revenue growth and strategic initiatives versus weak momentum and valuation issues. The stock is rated Neutral by Spark, TipRanks’ AI Analyst, with a YTD price performance of -32.86% and a market cap of $94.49M.

    Tip Ranks·
    US
    ZOMDF
    -2.20%
    Tip Ranks·
    US
    ZOMDF
    -2.20%

    Zomedica Corp. Senior VP Russell Kevin Klass Acquires 120,000 Shares

    Reporter NameKlass Russell KevinRelationshipSr Vice President, SalesTypePurchaseAmount$11,760SEC FilingForm 4Russell Kevin Klass, Senior Vice President of Sales at Zomedica Corp., purchased 120,000 shares of common stock on November 10, 2025, at a price of $0.098 per share, totaling $11,760. Following this transaction, Klass directly owns 5,634,101 shares of Zomedica Corp.SEC Filing: Zomedica Corp. [ ZOMDF ] - Form 4 - Nov. 12, 2025

    TradingView·
    US
    ZOMDF
    -2.20%
    TradingView·
    US
    ZOMDF
    -2.20%

    Zomedica Corp. Hosts "Friday at Four" Webinar Featuring Strategic Overview and Q3 Review

    Zomedica Corp. will host a "Friday at Four" investor webinar on November 21, 2025, at 4:00 p.m. ET. The session will cover a strategic overview of the company's product platforms, a review of Q3 2025 performance, and execution priorities for the remainder of 2025 and into 2026.

    Reuters·
    US
    ZOMDF
    -2.20%
    US
    ZOM
    0.00%
    Reuters·
    US
    ZOMDF
    -2.20%
    US
    ZOM
    0.00%

    Zomedica Corp. Senior Vice President of Sales Russell Kevin Klass Acquires Common Shares

    Russell Kevin Klass, Senior Vice President of Sales at Zomedica Corp., has acquired common shares of the company. The full filing is available through the provided link. This news was generated by Public Technologies and is for informational purposes only, not to be considered as financial or legal advice. Zomedica Corp. published the original content via EDGAR on November 07, 2025.

    Reuters·
    US
    ZOM
    0.00%
    Reuters·
    US
    ZOM
    0.00%

    Zomedica Reports Record Revenue Growth in Q3 2025

    Zomedica Corp., an animal health company, reported a 16% revenue increase in Q3 2025, reaching $8.1 million, marking 19 consecutive quarters of growth. The company achieved a gross margin of 67% and has $54 million in cash. Key highlights include a 51% growth in Diagnostics and a new Development Services segment contributing $0.7 million. Despite a net loss of $6.1 million, Zomedica is optimistic about future profitability and plans to expand its product offerings and international presence.

    Tip Ranks·
    US
    ZOMDF
    -2.20%
    Tip Ranks·
    US
    ZOMDF
    -2.20%
    © 2025 Longbridge｜Disclaimer